Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» LentiGlobin
LentiGlobin
Bluebird Bio Presents Promising Results for Gene Therapy in Rare Blood Disorder
CP Wire
Fri, 06/15/18 - 10:01 am
Bluebird Bio
gene therapy
LentiGlobin
beta thalassemia
sickle cell disease
Bluebird Bio Announces More Good News for LentiGlobin Gene Therapy – Exciting Results in Sickle Cell Disease
Fri, 06/15/18 - 09:51 am
Bluebird Bio
sickle cell disease
LentiGlobin
Bluebird Bio Presents Promising Results for Gene Therapy in Rare Blood Disorder
Fri, 06/15/18 - 09:39 am
Bluebird Bio
β-thalassemia
sickle cell disease
LentiGlobin
2 Beta Thalassemia Drugs Are Fast Approaching the Finish Line
Motley Fool
Sun, 04/22/18 - 11:52 am
Celgene
Bluebird Bio
beta thalassemia
LentiGlobin
luspatercept
Is bluebird bio One Step Closer to Its First Commercial Drug?
Motley Fool
Fri, 04/20/18 - 09:58 am
Bluebird Bio
beta thalassemia
LentiGlobin
JPM18: bluebird set to file 3 drugs for approval by 2019
Biopharma Dive
Wed, 01/10/18 - 10:21 am
Bluebird Bio
JPMHC 2018
Lenti-D
gene therapy
LentiGlobin
bb2121
9 Notable Biotechs Presenting At This Year's ASH Meeting
Yahoo
Tue, 11/7/17 - 09:56 am
ASH
Bluebird Bio
LentiGlobin
Ziopharm Oncology
Bellicum
BPX-501
Spark Therapeutics
SPK-8011
Biomarin
BMN 270
Juno Therapeutics
CAR-T
Novartis
Geron
imetelstat
Immunogen
IMGN632
IMGN779
Bluebird Reports Early Results From Upgraded Gene Therapy
Xconomy
Fri, 06/23/17 - 09:46 am
Bluebird Bio
LentiGlobin
gene therapy
clinical trials
beta-thalassemia
Bluebird touts upgrades to gene therapy, but shares slip
BioPharma Dive
Mon, 10/17/16 - 11:44 am
Bluebird Bio
gene therapy
LentiGlobin
10 Must-Know Biotech Stock Events to Close Out 2016
TheStreet.com
Fri, 09/9/16 - 09:04 pm
biotech
Eli Lilly
solanezumab
Biogen
aducanumab
Kite Pharma
KTE-C19
Bluebird Bio
LentiGlobin
Sarepta Therapeutics
eteplirsen
Ophthotech
Fovista
Bristol-Myers Squibb
Opdvio
Acadia
Nuplazid
Celgene
GED-301
Gilead Sciences
M&A
Bluebird bio adds a key process to pioneering gene therapy as it ramps up a pivotal PhIII
Endpoints
Thu, 09/8/16 - 06:28 pm
Bluebird Bio
gene therapy
LentiGlobin
Bluebird Sickle Cell Gene Therapy Falls Short of High Expectations
TheStreet.com
Sun, 12/6/15 - 11:04 am
Bluebird Bio
sickle cell disease
gene therapy
LentiGlobin
What's in bluebird bio's Pipeline That Has Investors So Excited?
Motley Fool
Sun, 07/19/15 - 05:35 pm
Bluebird Bio
gene therapy
LentiGlobin
beta-thalassemia
sickle cell disease
Bluebird Bio Gets Wall Street Love For Drug Results
Investors.com
Tue, 06/16/15 - 09:09 am
Bluebird Bio
LentiGlobin
sickle cell disease
Advisory Panel Recommends Bluebird Delay Gene Therapy Clinical Trial
TheStreet.com
Wed, 06/10/15 - 09:04 am
Bluebird Bio
advisory panels
FDA
gene therapy
LentiGlobin
Bluebird bio soars after drug developer details research into genetic blood disease treatment
Yahoo/AP
Tue, 12/9/14 - 09:49 am
Bluebird Bio
LentiGlobin
Bluebird, Agios: Preview of Next Week's Important Pipeline Updates
TheStreet.com
Fri, 06/6/14 - 09:34 am
Bluebird Bio
Agios
AG-221
Celgene
LentiGlobin
Pages
« first
‹ previous
1
2